Viewing Study NCT03513666


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2025-12-26 @ 6:40 PM
Study NCT ID: NCT03513666
Status: COMPLETED
Last Update Posted: 2023-08-23
First Post: 2018-04-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Toripalimab+ Pemetrexed Plus Carboplatin in Patients With EGFR-mutation Positive and T790M Negative After Progression on EGFR-TKI Treatment
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module